Medacta Group SA (SWX:MOVE)
132.20
+0.20 (0.15%)
Aug 3, 2026, 5:30 PM CET
Medacta Group Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 33.21 | 31.59 | 20.79 | 32.26 | 20.4 |
Short-Term Investments | 3.91 | 4.69 | 7.05 | 0.8 | - |
Cash & Short-Term Investments | 37.12 | 36.28 | 27.84 | 33.06 | 20.4 |
Cash Growth | 2.32% | 30.30% | -15.79% | 62.04% | -58.67% |
Accounts Receivable | 121.13 | 108.17 | 94.65 | 77.96 | 59.44 |
Other Receivables | 20.37 | 16.52 | 12.05 | 12.34 | 12.1 |
Total Trade Receivables | 141.49 | 124.69 | 106.7 | 90.3 | 71.54 |
Inventory | 271.42 | 234.41 | 213.92 | 160.3 | 136.09 |
Total Current Assets | 450.03 | 395.38 | 348.47 | 283.66 | 228.03 |
Net Property, Plant & Equipment | 386 | 317.5 | 267.34 | 218.5 | 179.75 |
Other Intangible Assets | 61.61 | 53.63 | 51.42 | 50.19 | - |
Goodwill | - | - | - | - | 51.98 |
Long-Term Investments | 1.44 | 1 | 0.71 | 0.48 | 0.48 |
Other Long-Term Assets | 18.57 | 24.68 | 27.94 | 31.66 | 29.03 |
Total Assets | 917.64 | 792.18 | 695.87 | 584.49 | 489.27 |
Accounts Payable | 49.83 | 35.39 | 38.85 | 28.48 | 25.95 |
Accrued Expenses | 45.43 | 43.95 | 40.16 | 31.49 | 29.06 |
Current Portion of Long-Term Debt | 90.45 | 50.83 | 46.92 | 7.09 | 64.49 |
Current Portion of Leases | 14.05 | 10.33 | 8.61 | 6.36 | 5.71 |
Other Current Liabilities | 16.94 | 17.06 | 14.87 | 15.64 | 11.35 |
Total Current Liabilities | 216.7 | 157.55 | 149.42 | 89.06 | 136.56 |
Long-Term Debt | 114.5 | 143.36 | 116.09 | 137.59 | 49.55 |
Long-Term Leases | 43.77 | 39.36 | 32.14 | 21.37 | 15.47 |
Other Long-Term Liabilities | 86.1 | 72.25 | 68.19 | 61.81 | 61.29 |
Total Long-Term Liabilities | 244.36 | 254.97 | 216.41 | 220.77 | 126.31 |
Total Liabilities | 461.07 | 412.51 | 365.83 | 309.83 | 262.87 |
Common Stock | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 |
Treasury Stock | -11.9 | -9.48 | -8.07 | -4.16 | - |
Additional Paid-in Capital | - | - | 10.49 | 16.02 | 21.23 |
Accumulated Other Comprehensive Income | 32.95 | 36.4 | 43.53 | 21.14 | 11.03 |
Retained Earnings | 433.76 | 350.97 | 282.32 | 239.88 | 192.36 |
Shareholders' Equity | 456.58 | 379.66 | 330.04 | 274.66 | 226.4 |
Total Liabilities & Equity | 917.64 | 792.18 | 695.87 | 584.49 | 489.27 |
Total Debt | 262.77 | 243.87 | 203.76 | 172.42 | 135.22 |
Net Cash (Debt) | -225.65 | -207.59 | -175.92 | -139.35 | -114.82 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -11.30 | -10.40 | -8.80 | -6.97 | -5.74 |
Book Value | 456.58 | 379.66 | 330.04 | 274.66 | 226.4 |
Book Value Per Share | 22.86 | 19.03 | 16.51 | 13.74 | 11.32 |
Tangible Book Value | 394.97 | 326.04 | 278.62 | 224.47 | 174.42 |
Tangible Book Value Per Share | 19.78 | 16.34 | 13.94 | 11.23 | 8.72 |